More about

Headache

News
November 08, 2022
1 min read
Save

Case study: COVID-19-induced hyposmia prevented migraines triggered by strong odors

Case study: COVID-19-induced hyposmia prevented migraines triggered by strong odors

CHICAGO — COVID-19-induced hyposmia eliminated odor-induced migraine headaches in an older adult, a case study presented at the 2022 American Neurological Association’s annual meeting showed.

News
October 28, 2022
2 min read
Save

Over 1.5 million US vets diagnosed with headache: improved outreach, care needed

Over 1.5 million US vets diagnosed with headache: improved outreach, care needed

CHICAGO — With more than 1.5 million veterans diagnosed with headache over the past two decades, the Veterans Health Administration must improve outreach and care to address disparities, an expert said at ANA 2022.

News
October 19, 2022
3 min read
Save

Evaluate headache characteristics to classify as migraine

Evaluate headache characteristics to classify as migraine

LAS VEGAS — Certain red flags can indicate that a patient’s headaches are the migraine type, Merle Diamond, MD, said at PAINWeek 2022.

News
October 18, 2022
1 min read
Save

Theranica announces positive results from clinical trial for migraine treatment device

Theranica announces positive results from clinical trial for migraine treatment device

Theranica Bio-electronics announced positive top-line results from a double-blind, randomized, placebo-controlled, multicenter clinical trial to evaluate efficacy and safety of Nerivio for the treatment of episodic and chronic migraine.

News
September 12, 2022
2 min read
Save

Obefazimod bests placebo, improves ulcerative colitis in phase 2b induction trial

Obefazimod bests placebo, improves ulcerative colitis in phase 2b induction trial

Obefazimod improved moderate to severe ulcerative colitis compared with placebo in patients with documented nonresponse or intolerance to previous treatment, according to new data published in The Lancet Gastroenterology & Hepatology.

News
September 02, 2022
1 min read
Save

Diamond Headache Clinic to present migraine tracks at PAINWeek, BRAINWeek 2022

Diamond Headache Clinic to present migraine tracks at PAINWeek, BRAINWeek 2022

The 2022 PAINWeek and BRAINWeek conferences, Sept. 6-9 and Sept. 28-30 in Las Vegas, will feature migraine tracks presented by the world-renowned Diamond Headache Clinic.

News
August 09, 2022
1 min read
Save

Fatigue, headache most common long COVID symptoms

Fatigue, headache most common long COVID symptoms

Fatigue and headache were the most common symptoms reported by people an average of 4 months after COVID-19 infection, according to research in Brain, Behavior, & Immunity.

News
June 29, 2022
2 min read
Save

Acupuncture effective in treating symptoms of chronic tension-type headache

Acupuncture effective in treating symptoms of chronic tension-type headache

An 8-week course of true acupuncture reduced the monthly number of headache days in patients with chronic tension-type headache, with treatment effects lasting for 32 weeks, according to a study published in Neurology.

News
June 16, 2022
2 min watch
Save

VIDEO: Migraine prevalence stable, burden on rise throughout U.S.

VIDEO: Migraine prevalence stable, burden on rise throughout U.S.

DENVER — Although migraine prevalence has remained stable over the past 30 years, measures of burden, including MIDAS scores, have steadily increased, Fred Cohen, MD, said at the American Headache Society’s annual scientific meeting.

News
June 13, 2022
1 min read
Save

Fewer monthly migraine days observed after 6 months of Vyepti vs. placebo

Fewer monthly migraine days observed after 6 months of Vyepti vs. placebo

DENVER — Treatment with Vyepti was associated with a sustained reduction in the frequency of episodic and chronic migraines over 6 months, researchers reported at the American Headache Society annual scientific meeting.

View more